Nuwellis (NUWE) Other Non-Current Liabilities (2015 - 2026)
Nuwellis (NUWE) posted Other Non-Current Liabilities of $362000.0 for Q1 2026, down 6.94% on a QoQ basis from $389000.0 in Q4 2025, and down 15.02% year-over-year from $426000.0 in Q1 2025.
Nuwellis (NUWE) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
Nuwellis' Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $362000.0 for Q1 2026.
- Quarterly Other Non-Current Liabilities fell 15.02% year-over-year to $362000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $362000.0 (down 15.02% YoY) and the FY2025 annual result came in at $389000.0, down 16.88% from the prior year.
- Other Non-Current Liabilities was $362000.0 for Q1 2026 at Nuwellis, down from $389000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $10.0 million in Q2 2025 and bottomed at $71000.0 in Q1 2022.
- A 5-year average of $2.7 million and a median of $474000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities tumbled 83.54% — and 2025, when it rose 16.56%.
- Nuwellis' Other Non-Current Liabilities stood at $6.9 million in 2022, then plunged by 58.61% to $2.8 million in 2023, then tumbled by 83.54% to $468000.0 in 2024, then slipped by 16.88% to $389000.0 in 2025, then dropped by 6.94% to $362000.0 in 2026.
- Business Quant data shows NUWE's Other Non-Current Liabilities at $362000.0 in Q1 2026, $389000.0 in Q4 2025, and $420000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,000.00 |
| Dec 31, 2025 | 389,000.00 |
| Sep 30, 2025 | 420,000.00 |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 8.58 Mn |
| Mar 31, 2024 | 964,000.00 |
| Dec 31, 2023 | 2.84 Mn |
| Dec 31, 2022 | 6.87 Mn |
| Mar 31, 2022 | 71,000.00 |
| Sep 30, 2021 | 286,000.00 |
| Sep 30, 2018 | 126,000.00 |
| Jun 30, 2018 | 126,000.00 |
| Mar 31, 2018 | 126,000.00 |
| Dec 31, 2017 | 126,000.00 |
| Sep 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 10,000.00 |
| Mar 31, 2017 | 126,000.00 |